Home ENGLISH ARTICLES BREAKING: EVIL FDA Authorizes KILLER Pfizer Booster Shot for Children Ages 5 to 11 Years Old

BREAKING: EVIL FDA Authorizes KILLER Pfizer Booster Shot for Children Ages 5 to 11 Years Old

by _
0 comment 198 views
BREAKING: EVIL FDA Authorizes KILLER Pfizer Booster Shot for Children Ages 5 to 11 Years Old
BREAKING: EVIL FDA Authorizes KILLER Pfizer Booster Shot for Children Ages 5 to 11 Years Old

BREAKING: FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years Old

“The FDA is authorizing the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age to provide continued protection against COVID-19. Vaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe. If your child is eligible for the Pfizer-BioNTech COVID-19 Vaccine and has not yet received their primary series, getting them vaccinated can help protect them from the potentially severe consequences that can occur, such as hospitalization and death.”

More from their news release:

Data Supporting Effectiveness

 

The EUA for a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is based on FDA’s analysis of immune response data in a subset of children from the ongoing randomized placebo-controlled trial that supported the October 2021 authorization of the Pfizer-BioNTech COVID-19 Vaccine primary series in this age group. Antibody responses were evaluated in 67 study participants who received a booster dose 7 to 9 months after completing a two-dose primary series of the Pfizer-BioNTech COVID-19 Vaccine. The antibody level against the SARS-CoV-2 virus one month after the booster dose was increased compared to before the booster dose.

 

FDA Evaluation of Safety

 

The safety of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine in this age group was assessed in approximately 400 children who received a booster dose at least five months (range 5 to 9 months) after completing a two-dose primary series. The most commonly reported side effects were pain, redness and swelling at the injection site, as well as fatigue, headache, muscle or joint pain and chills and fever.

 



 

The FDA did not hold a meeting of its Vaccines and Related Biological Products Advisory Committee on today’s action, as the agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of Pfizer’s EUA request, the FDA concluded that the request did not raise questions that would benefit from additional discussion by committee members. The FDA will make available on its website relevant documents regarding today’s authorization.

 

The amendment to the EUA was granted to Pfizer Inc.

Last December, FDA authorized the Pfizer Covid booster shot for 16 and 17-year-olds just in time for the Omicron variant. The announcement comes just one day after Pfizer said protection against the Omicron variant improves with three jabs.

You may also like

Είμαστε μια ομάδα που αποτελείται απο δημοσιογράφους, ερευνητές, εκφωνητές, οικονομολόγους και όχι μόνο. Αν έχετε τυχόν ερωτήσεις, είμαστε στη διάθεσή σας στο ακόλουθο e-mail.

Contact: [email protected]

@ 2022 – All Right Reserved. Designed and Developed by WebLegends.gr